Central nervous system neurotransmitter activity, control

Hydroxy tryptamine, or serotonin, is a neurotransmitter in the central nervous system (CNS). The nerve-cell bodies of the major serotoninergic neurones are in the midline raphe nuclei of the rostral pons, and ascending fibers innervate the basal ganglia, hypothalamus, thalamus, hippocampus, limbic forebrain, and areas of the cerebral cortex. The serotoninergic system plays an important role in the control of mood and behavior, motor activity, hunger, thermoregulation, sleep, certain hallucinatory states, and some neuro-endocrine mechanisms. 

The amino acid L-glutamate is the main excitatory neurotransmitter of the central nervous system (Fonnum, 1984). Glutamate exerts its excitatory effects either by activation of several G-protein-coupled metabotropic glutamate receptors or by induction of ion fluxes by different classes of ionotropic receptors. The NMDA receptor is one of those glutamate-gated ion channels which got its name from its selective artificial agonist NMDA (N-methyl-D-aspartate) and which controls slow but persistent ion fluxes of Na+, K+, and Ca2+ across the cell membrane. 

The release of stored neurotransmitters is a consequence of activation of neuronal S-HTg receptors increasing intracellular calcium concentrations. Thus, 5-HT, has long heen known to control the release of acetylcholine (ACh) and noradrenaline (NA) in peripheral tissues. In the central nervous system, the release of NA, ACh, 5-HT, dopamine (DA) and cholecystokinin (CCK) have been shown to be modulated by several 5-HT3 drugs. These biochemical effects, in addition to the presence of 5-HTj sites in expected areas, support behavioural experiments which have estabUshed the putative therapeutic characteristics of 5-HT3 receptor antagonists. 

As to be expected from a peptide that has been highly conserved during evolution, NPY has many effects, e.g. in the central and peripheral nervous system, in the cardiovascular, metabolic and reproductive system. Central effects include a potent stimulation of food intake and appetite control [2], anxiolytic effects, anti-seizure activity and various forms of neuroendocrine modulation. In the central and peripheral nervous system NPY receptors (mostly Y2 subtype) mediate prejunctional inhibition of neurotransmitter release. In the periphery NPY is a potent direct vasoconstrictor, and it potentiates vasoconstriction by other agents (mostly via Yi receptors) despite reductions of renal blood flow, NPY enhances diuresis and natriuresis. NPY can inhibit pancreatic insulin release and inhibit lipolysis in adipocytes. It also can regulate gut motility and gastrointestinal and renal epithelial secretion. 

---